-- 根據FactSet調查的分析師報告，Markel Group (MKL) 的平均評級為“持有”，平均目標價為2,079.25美元。 （報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們：https://www..com/contact-us）
Price: $1738.01, Change: $-21.20, Percent Change: -1.21%
Related Articles
Australia
Amazon's Backlog Ramp Points to Accelerating Revenue Growth, UBS Says
Amazon's (AMZN) backlog ramp, including $100 billion from Anthropic, points to accelerating revenue growth in 2026 and 2027, UBS said in a Thursday report."While there may still be some variability on the magnitude, the backlog ramp continues to point the way to accelerating revenue growth throughout 2026 and 2027, which should in turn raise investor confidence on ROIC," the note said. ROIC refers to return on invested capital.For 2026, the base case for Amazon Web Services growth is now 36%, the report said, adding that consolidated near-term revenue estimates have also moved up, driven by the e-commerce business following Q1 beat.UBS reiterated its buy rating and boosted its price target to $333 from $304.Price: $259.19, Change: $-3.85, Percent Change: -1.46%
$AMZN
Australia
Wells Fargo Adjusts Price Target on CoStar Group to $33 From $40
CoStar Group (CSGP) has an average rating of overweight and mean price target of $50.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $34.15, Change: $+0.01, Percent Change: +0.03%
$CSGP
Australia
Morgan Stanley Adjusts Price Target on AbbVie to $278 From $270
AbbVie (ABBV) has an average rating of overweight and mean price target of $253.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $213.21, Change: $+9.32, Percent Change: +4.57%
$ABBV